Veradermics (MANE) Operating Expenses (2025 - 2026)

Veradermics (MANE) has 2 years of Operating Expenses data on file, last reported at $29.9 million in Q1 2026.

• Quarterly Operating Expenses rose 131.22% year-over-year to $29.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.8 million (changed N/A YoY) and the FY2025 annual result came in at $72.3 million, up 170.17% from the prior year.
• Operating Expenses improved to $29.9 million in Q1 2026, from $12.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $29.9 million in Q1 2026 to a low of $12.9 million in Q1 2025.